OM-85
Sponsors
Dr. Sami Ulus Children's Hospital, OM Pharma SA
Conditions
Adenoid HyperplasiaAdenoid HypertrophyPreschool ChildrenRecurrent WheezingRespiratory Tract InfectionsWheezing Lower Respiratory Illness
Phase 2
Phase 4
Effect of OM-85 on Respiratory Tract Infections and Adenoid Tissue in Children With Adenoid Hypertrophy
NCT03243565
Start: 2017-11-01End: 2019-05-01Target: 68Updated: 2017-10-05
OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
Active, not recruitingNCT05677763
Start: 2022-12-12End: 2026-09-16Updated: 2026-08-03